What is Thermo Fisher Scientific's market cap?

Thermo Fisher Scientific (TMO) has a market capitalization of $189.58B and trades on NYSE.

What is Thermo Fisher Scientific's revenue and profitability?

Thermo Fisher Scientific generated $43.4B in trailing twelve-month revenue with net income of $6.8B, representing a net margin of 15.2%. Gross margin stands at 58.3%, with free cash flow of $6.7B. These figures are based on the Q1 2026 filing.

Who are Thermo Fisher Scientific's competitors?

Thermo Fisher Scientific's key competitors include Agilent Technologies, Danaher Corporation, Revvity, Inc., and others. These companies compete in similar markets and product categories.

What subsidiaries does Thermo Fisher Scientific have?

Thermo Fisher Scientific's subsidiaries include Patheon, PPD, Fisher Scientific, and others.

Where is Thermo Fisher Scientific headquartered?

Thermo Fisher Scientific is headquartered in United States of America and employs approximately 122,000 people. It has been publicly traded since 1972.

Thermo Fisher Scientific

TMO

Thermo Fisher Scientific is a global leader in life sciences, providing a comprehensive portfolio of analytical instruments, laboratory equipment, software, and services.

Market cap

$189.58B+17.0%

Revenue$43.4B+2.4%

Net income$6.8B+5.1%

Free cash flow$6.7B+0.4%

EPS (diluted)$18.19+6.7%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 23, 2026

Revenue$11.0BBeat by $140.3M EPS$5.44Beat by $0.19

Read the full report

Next report

Jul 23, 2026 (In 1 week)

Revenue estimate$11.7B

EPS estimate$5.71

Financials

Q1 2026

Income statement

See full

Revenue$11.0B+6.2%

Operating income$1.9B+8.6%

Net income$1.7B+9.6%

EPS (diluted)$4.43+11.3%

Balance sheet

See full

Cash & equivalents$3.3B-21.4%

Total debt$43.2B+16.6%

Total equity$51.9B+5.2%

Total assets$113.28B+14.4%

Cash flow

See full

Operating cash flow$1.2B+64.9%

CapEx$376.0M+3.9%

Free cash flow$816.0M+126%

Valuation & ratios

Valuation

See full

Market cap$189.58B+17.0%

Enterprise value$229.46B+17.7%

P/E27.7×+3.1×

P/S4.4×—

Returns & leverage

See full

Return on equity13.5%-0.2pp

Debt / equity0.8×+0.1×

Current ratio1.5×-0.2×

Segments

By segment

See full

Laboratory Products and Biopharma Services$6.0B+7.0%

Life Sciences Solutions$2.6B+12.6%

Analytical Instruments$1.7B-0.1%

Specialty Diagnostics$1.1B-0.5%

By geography

See full

North America$5.7B+3.5%

Europe$3.0B+12.7%

Asia-Pacific$2.0B+4.2%

Other regions$372.0M+10.4%

By product

See full

Service revenues$4.7B+7.8%

Consumables$4.7B+8.5%

Instruments$1.6B-4.4%

Competitors

By market cap

Thermo Fisher Scientific$189.58B+17.0%

Danaher$135.02B-7.2%

Agilent Technologies$36.5B+5.7%

WAT

Waters Corporation$36.1B+73.4%

Illumina$28.4B+78.1%

Revvity$12.2B+2.2%

TEC

Bio-Techne$11.1B+32.7%

Bio-Rad Laboratories$7.6B+11.0%

By revenue growth

WAT

Waters Corporation+26.4%

Agilent Technologies+9.1%

Revvity+4.8%

Danaher+4.0%

Thermo Fisher Scientific+2.4%

Bio-Rad Laboratories+1.9%

Illumina+1.3%

TEC

Bio-Techne+0.2%

By net margin

Agilent Technologies19.55%+2.0pp

Illumina19.42%+41.7pp

Thermo Fisher Scientific15.19%+0.4pp

Danaher14.89%-0.9pp

WAT

Waters Corporation11.91%-10.1pp

TEC

Bio-Techne10.89%-0.7pp

Revvity8.26%-2.1pp

Bio-Rad Laboratories6.52%+91.7pp

Profile

Thermo Fisher Scientific is a global leader in life sciences, providing a comprehensive portfolio of analytical instruments, laboratory equipment, software, and services. The company enables scientific research, clinical diagnostics, and pharmaceutical manufacturing through a combination of innovative technology and end-to-end laboratory solutions.

Competitive position

The company maintains a dominant market position as a 'one-stop shop' for scientific research, leveraging massive scale and a deep portfolio of proprietary brands.

GeographiesNorth America, Europe, Asia-Pacific, Rest of World

Customer segmentsPharmaceutical and Biotech, Academic and Government, Industrial and Applied, Healthcare and Diagnostics

Business modelManufacturing, Contract Development and Manufacturing (CDMO), Direct Sales, Distribution

SuppliersRaw material suppliers, Specialized component manufacturers, Chemical and reagent feedstock providers

CustomersDrug development pipelines, Clinical patient testing, Environmental monitoring programs, Academic research projects

CountryUnited States of America

Listed1972

Employees122.0K

CEOMarc N. Casper

SectorHealthcare

IndustryMedical - Diagnostics & Research

Websitethermofisher.com

FilingsSEC EDGAR

Ask your AI about Thermo Fisher Scientific.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Thermo Fisher Scientific's market cap?: Thermo Fisher Scientific (TMO) has a market capitalization of $189.58B and trades on NYSE.
What is Thermo Fisher Scientific's revenue and profitability?: Thermo Fisher Scientific generated $43.4B in trailing twelve-month revenue with net income of $6.8B, representing a net margin of 15.2%. Gross margin stands at 58.3%, with free cash flow of $6.7B. These figures are based on the Q1 2026 filing.
Who are Thermo Fisher Scientific's competitors?: Thermo Fisher Scientific's key competitors include Agilent Technologies, Danaher Corporation, Revvity, Inc., and others. These companies compete in similar markets and product categories.
What subsidiaries does Thermo Fisher Scientific have?: Thermo Fisher Scientific's subsidiaries include Patheon, PPD, Fisher Scientific, and others.
Where is Thermo Fisher Scientific headquartered?: Thermo Fisher Scientific is headquartered in United States of America and employs approximately 122,000 people. It has been publicly traded since 1972.